抗血管内皮生长因子药物治疗作为增殖性糖尿病视网膜病变全视网膜激光光凝术的替代疗法 - Suppr

Suppr

超能文献

Anti-VEGF Pharmacotherapy as an Alternative to Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy.

作者信息

Olsen Timothy W

机构信息

Emory Eye Clinic, Department of Ophthalmology, Emory University, Atlanta, Georgia.

出版信息

JAMA. 2015 Nov 24;314(20):2135-6. doi: 10.1001/jama.2015.15409.

DOI:10.1001/jama.2015.15409

PMID:26565713

Abstract

摘要

相似文献

Anti-VEGF Pharmacotherapy as an Alternative to Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy.抗血管内皮生长因子药物治疗作为增殖性糖尿病视网膜病变全视网膜激光光凝术的替代疗法

JAMA. 2015 Nov 24;314(20):2135-6. doi: 10.1001/jama.2015.15409.

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.全视网膜光凝与玻璃体内注射雷珠单抗治疗增殖性糖尿病视网膜病变的随机临床试验

JAMA. 2015 Nov 24;314(20):2137-2146. doi: 10.1001/jama.2015.15217.

Diabetes: Intravitreous ranibizumab for proliferative diabetic retinopathy.糖尿病：玻璃体内注射雷珠单抗治疗增殖性糖尿病视网膜病变。

Nat Rev Endocrinol. 2016 Mar;12(3):130-1. doi: 10.1038/nrendo.2016.1. Epub 2016 Jan 22.

Lucentis offers treatment alternative for diabetic retinopathy, trial finds.试验发现，雷珠单抗为糖尿病性视网膜病变提供了治疗选择。

BMJ. 2015 Nov 16;351:h6145. doi: 10.1136/bmj.h6145.

Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study.雷珠单抗、全视网膜激光光凝或联合治疗后增殖性糖尿病视网膜病变患者的观察性结局——PRIDE研究的非干预性第二年随访

Acta Ophthalmol. 2022 Mar;100(2):e578-e587. doi: 10.1111/aos.14907. Epub 2021 Jun 14.

PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?光凝术与雷珠单抗治疗增生性糖尿病视网膜病变：基线特征是否会影响治疗选择？

Retina. 2019 Sep;39(9):1646-1654. doi: 10.1097/IAE.0000000000002377.

Infographic: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy (PDR): DRCR.net Protocol S.信息图：全视网膜光凝术与玻璃体内注射雷珠单抗治疗增殖性糖尿病视网膜病变（PDR）：糖尿病视网膜病变临床研究网方案S

Eye (Lond). 2024 Aug;38(Suppl 2):37-38. doi: 10.1038/s41433-023-02396-0. Epub 2023 Apr 21.

Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab.在接受全视网膜光凝治疗且接受或未接受玻璃体内注射雷珠单抗的非高危增殖性糖尿病视网膜病变患者中对比敏感度的评估。

Arq Bras Oftalmol. 2022 Jan-Feb;85(1):37-45. doi: 10.5935/0004-2749.20220006.

Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy.比较增生性糖尿病视网膜病变患者中雷珠单抗与全视网膜光凝治疗的中期安全性数据。

JAMA Ophthalmol. 2017 Jun 1;135(6):672-673. doi: 10.1001/jamaophthalmol.2017.0969.

Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.玻璃体内注射雷珠单抗与全视网膜光凝治疗增殖性糖尿病视网膜病变的成本效益：糖尿病视网膜病变临床研究网络随机临床试验的二次分析

JAMA Ophthalmol. 2017 Jun 1;135(6):576-584. doi: 10.1001/jamaophthalmol.2017.0837.

引用本文的文献

Relationship of fibroblast growth factor 21, Klotho, and diabetic retinopathy: a meta-analysis.成纤维细胞生长因子 21、Klotho 与糖尿病视网膜病变的关系：一项荟萃分析。

Front Endocrinol (Lausanne). 2024 Aug 27;15:1390035. doi: 10.3389/fendo.2024.1390035. eCollection 2024.

Role of apigenin in high glucose-induced retinal microvascular endothelial cell dysfunction regulating NOX4/p38 MAPK pathway .芹菜素在高糖诱导的视网膜微血管内皮细胞功能障碍中通过调节NOX4/p38 MAPK信号通路发挥的作用

Int J Ophthalmol. 2023 Apr 18;16(4):514-522. doi: 10.18240/ijo.2023.04.04. eCollection 2023.

Effect of pan-retinal laser photocoagulation on intravitreal vascular endothelial growth factor concentration in proliferative diabetic retinopathy.全视网膜激光光凝治疗对增生型糖尿病视网膜病变患者眼内血管内皮生长因子浓度的影响。

Rom J Ophthalmol. 2022 Jul-Sep;66(3):265-270. doi: 10.22336/rjo.2022.49.

Ferulic acid attenuates high glucose-induced apoptosis in retinal pigment epithelium cells and protects retina in db/db mice.阿魏酸可减轻高糖诱导的视网膜色素上皮细胞凋亡，并保护 db/db 小鼠的视网膜。

PeerJ. 2022 May 31;10:e13375. doi: 10.7717/peerj.13375. eCollection 2022.

Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy.糖尿病患者的视网膜中视黄醇结合蛋白 3 增加，而这些患者对糖尿病性视网膜病变有抗性。

Sci Transl Med. 2019 Jul 3;11(499). doi: 10.1126/scitranslmed.aau6627.

Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy.三七总皂苷 R1 通过 PINK1 依赖性自噬激活减轻糖尿病视网膜病变。

Cells. 2019 Mar 2;8(3):213. doi: 10.3390/cells8030213.

Recent novel approaches to limit oxidative stress and inflammation in diabetic complications.限制糖尿病并发症中氧化应激和炎症的最新新方法。

Clin Transl Immunology. 2018 Apr 18;7(4):e1016. doi: 10.1002/cti2.1016. eCollection 2018.

Single-dose Intravitreal Bevacizumab after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: an Effective Adjunctive Treatment.增殖性糖尿病视网膜病变全视网膜光凝术后玻璃体内注射单剂量贝伐单抗：一种有效的辅助治疗方法

Med Hypothesis Discov Innov Ophthalmol. 2017 Fall;6(3):76-81.

Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy.促血管生成和抗血管生成的血管内皮生长因子（VEGF）及其受体状态与糖尿病视网膜病变严重程度的关系

Mol Vis. 2017 Jun 22;23:356-363. eCollection 2017.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验